Company Filing History:
1 out of 1,001 
1 out of 1,866 
Years Active: 2019
Title: Innovations of Elizabeth R Sharlow in Cancer Treatment
Introduction
Elizabeth R Sharlow is a notable inventor based in Butler, PA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. Her work focuses on the inhibition of protein tyrosine phosphatase, which plays a crucial role in cancer progression.
Latest Patents
Elizabeth R Sharlow holds 1 patent for her invention titled "Inhibitors of PTP4A3 for the treatment of cancer." This patent provides a detailed description of protein tyrosine phosphatase inhibitor compounds, their pharmaceutical compositions, and methods of use in treating various cancers. Additionally, the patent discloses an improved synthesis process for the precursor compound thienopyridone (5), enhancing the efficiency of these inhibitors.
Career Highlights
Throughout her career, Elizabeth has worked with esteemed institutions such as the University of Virginia Patent Foundation and the University of Pittsburgh. Her dedication to research and innovation has positioned her as a key figure in the development of cancer therapies.
Collaborations
Elizabeth has collaborated with notable colleagues, including John S Lazo and Kelley E McQueeney. These partnerships have furthered her research and contributed to advancements in cancer treatment.
Conclusion
Elizabeth R Sharlow's innovative work in developing inhibitors for cancer treatment showcases her commitment to improving healthcare through scientific research. Her contributions are vital in the ongoing fight against cancer, and her patent reflects her dedication to this important field.